MENU
CABA
AS OF
Dec 24 closing price
Price
$2.19
Change
+$0.01 (+0.46%)
Capitalization
210.82M
77 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
CABA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Cabaletta Bio (CABA) Ownership - Who owns Cabaletta Bio?

Cabaletta Bio Inc is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies and exploring their potential to provide a deep and durable, perhaps curative, treatment for patients with B cell-mediated autoimmune diseases... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
2929 Arch Street
Phone
+1 267 759-3100
Employees
103
Web
https://www.cabalettabio.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
210.82M
P/E Ratio
N/A
Total Cash
159.93M
Projected Growth
N/A
Total Debt
25.78M
Revenue
N/A
Risk (Beta)
1.62
Dividend Yield
N/A
Total Cash/Share
1.66
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

CABA
Capitalization
211M
P/E Ratio
N/A
Risk (Beta)
1.62
Dividend Yield
N/A
Total Cash
160M
Total Cash/Share
1.66
Total Debt
25.8M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
139M
P/B Ratio
1.51
Cash Flow
N/A
Earnings
-2.4
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1K
Current Ratio
3.60
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-154.56M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-80.43
Shares Held By Institutions
221M
Shares Outstanding - Current
96.3M
Total Liabilities
50.3M
Total Volume MTD
N/A
Value
1
Gain YTD
-3.524
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
Swing Trader, Long Only with Inverse: Valuation Model for Energy Sector (TA&FA)Swing Trader, Long Only with Inverse: Valuation Model for Energy Sector (TA&FA)
Annualized Return+37%
VIEW DETAILSVIEW DETAILS
VIEW FOR FREEVIEW FOR FREE
CABA
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. CABA showed earnings on November 10, 2025. You can read more about the earnings report here.
View AI-Driven Trading for CABA
A.I. Advisor
published General Information

General Information

a clinical-stage biotechnology company, which engages in the discovery and development of engineered T cell therapies for B cell-mediated autoimmune diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
2929 Arch Street
Phone
+1 267 759-3100
Employees
103
Web
https://www.cabalettabio.com